期刊文献+

白细胞介素-18在早期心肌缺血和心肌梗死心肌的表达 被引量:3

An immunohistochemical study on IL-18 in early myocardial ischemia and myocardial infarction
下载PDF
导出
摘要 目的探讨白细胞介素-18(IL-18)对早期心肌缺血(EMI)和心肌梗塞(MI)死后诊断的法医学意义。方法筛选出34例心脏标本,分EMI(11例)、MI(10例)和对照(13例)组,检测心肌IL-18免疫组化染色(SP法)反应,并经全自动图像分析系统分析得到平均光密度值(AOD),所得数据进行统计学分析。结果对照组心肌IL-18免疫组化染色呈阴性,EMI组心肌呈阳性,MI组心肌呈强阳性;其AOD值分别是0.1193±0.0649、0.3827±0.0868、0.4792±0.0884,3组之间差异均具有显著性意义(P<0.05)。结论作为判断EMI和MI的指标之一,IL-18对EMI和MI的死后诊断具有法医学意义。 Objective To investigate applicability of interleukin-18 (IL-18) to diagnosing of early myocardial ischemia (EMI) and myocardial infarction (MI) in postmortem specimens. Methods Myocardial samples collected from 34 atuopsied cases were employed in the experiment, which were divided into 3 groups, EMI( 11 cases), MI( 10 cases), and control (13 cases). Immunoreactivity of IL-18 detected by immunohistochemical staining (S-P method), and average optical density (AOD) were analyzed by automatic image analysis technique. The data were processed statistically. Results Weak or negative immunoreactivity of IL-18 was noted in the normal myocardial spcimens (NM) , positive in the EMI and significantly positive in the MI spcimens. AOD of immunostaining was measured as 0.1193±0. 0649, 0. 3827 ±0.0868 and 0.4792 ± 0.0884, respectively. There were significant difference between two among the three groups (P 〈0.05). Conclusion It is indicated that IL-18 can be served as an predictor of EMI and MI, which may provide an method for postmortem diagnosis of EMI and MI.
出处 《中国法医学杂志》 CSCD 2007年第4期244-246,I0005,共4页 Chinese Journal of Forensic Medicine
关键词 法医病理学 白细胞介素-18(IL-18) 早期心肌缺血(EMI) 心肌梗死(MI) Forensic pathology Interleu kin-18, Early myocardial ischemia, Myocardial infarction.
  • 相关文献

参考文献7

  • 1Ushio S,Namba M,Okura J,et al.Clonging of the cDNA for human IFN-γ-inducing factor expression in Escherichia cell and studies on the biologic activities of the protein[J].J Immunol,1996,156 (9):4274-4283.
  • 2Pomerantz B J,Reznikov L L,Harken A H,et al.Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta[J].Proc Natl Acad Sci USA,2001,98 (5):2871 -2876.
  • 3武忠弼 杨光华主编.中华外科病理学[M].北京:人民卫生出版社,2002.646.
  • 4Youssef A A,Chang L T,Hang,C L,et al.Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty[J].Circ J,2007,71:703 -708.
  • 5Mallat Z,Heymes C,Corbaz A,et al.Evidence for altered interleukin (IL)-18 pathway in human heart failure[J].FASEB J,2004,18:1752-1754.
  • 6Yukihiro S,Tsugiasu K,Toru T,et al.Interleukin 18 in acute myocardial infarction[J].Heart,2000,84:668 -669.
  • 7Woldbaek P R,Sande J B,Stromme T A,et al.Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice[J].Am J Physiol Heart Circ Physiol,2005,289:708 -714.

共引文献545

同被引文献34

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部